Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001074227 | SCV001239800 | uncertain significance | Retinal dystrophy | 2019-04-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001364802 | SCV001560982 | uncertain significance | not provided | 2022-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 155 of the NR2E3 protein (p.Arg155His). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with NR2E3-related conditions. ClinVar contains an entry for this variant (Variation ID: 866331). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001828536 | SCV002085608 | uncertain significance | Enhanced S-cone syndrome | 2020-02-26 | no assertion criteria provided | clinical testing |